Drug Development
We have a robust portfolio of multiple pending patents for innovative first- and second-generation medications with a focus on safety and efficacy, as well as an excellent R&D staff and cutting-edge research facilities in Canada and the United States.
Clinical Trials
We've collaborated with leading worldwide research institutions to examine a number of medication candidates with the potential for greater effectiveness and other enhancements. The first clinical studies will focus on nicotine dependency and PTSD.
Technology
Technology is an important part of our business strategy, and we're using artificial intelligence and machine learning to scan billions of molecules for potential novel compounds.